سعر فاركوسولفين شراب 120 مل 2025

Oral syrup combining ambroxol (mucolytic), theophylline (bronchodilator) and guaifenesin (expectorant), 120 mL bottle.

• In the 2010 randomized trial (5 mL three times daily for 7 days), 7 of 50 Farcosolvin-treated patients reported adverse events, including nausea (5 patients) and heartburn; no serious adverse events occurred.International label, same product

• Ambroxol (as hydrochloride):
• Theophylline (anhydrous): Relaxes airway smooth muscle (bronchodilation) and suppresses airway responsiveness to stimuli; bronchodilation is thought to be mediated by inhibition of phosphodiesterase isozymes PDE III and, to a lesser extent, PDE IV (US label; mechanisms not known with certainty).
• Guaifenesin: May irritate gastric vagal receptors recruiting parasympathetic reflexes that increase less-viscous respiratory secretions.